[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2021 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-May-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Mar-2021 [#1]
Profit Trend
QoQ- -15.84%
YoY- 3.29%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 4,815,015 4,103,297 1,970,622 793,499 2,725,071 2,090,488 1,465,684 120.51%
PBT 277,075 151,987 53,768 31,524 35,793 49,299 45,206 233.81%
Tax -104,870 -64,947 -17,052 -8,696 -9,524 -15,983 -13,184 296.97%
NP 172,205 87,040 36,716 22,828 26,269 33,316 32,022 206.00%
-
NP to SH 172,150 86,675 36,840 23,136 27,489 33,820 32,378 203.70%
-
Tax Rate 37.85% 42.73% 31.71% 27.59% 26.61% 32.42% 29.16% -
Total Cost 4,642,810 4,016,257 1,933,906 770,671 2,698,802 2,057,172 1,433,662 118.42%
-
Net Worth 450,411 391,428 357,275 355,919 337,298 345,040 357,891 16.51%
Dividend
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Div 121,768 56,292 30,100 10,468 28,761 26,139 22,204 210.01%
Div Payout % 70.73% 64.95% 81.71% 45.25% 104.63% 77.29% 68.58% -
Equity
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Net Worth 450,411 391,428 357,275 355,919 337,298 345,040 357,891 16.51%
NOSH 1,309,336 1,309,126 261,991 261,705 261,705 261,705 261,705 191.66%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 3.58% 2.12% 1.86% 2.88% 0.96% 1.59% 2.18% -
ROE 38.22% 22.14% 10.31% 6.50% 8.15% 9.80% 9.05% -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 367.74 313.44 150.58 303.20 1,042.20 799.75 561.06 -24.48%
EPS 13.15 6.62 2.82 8.84 10.51 12.94 12.39 4.03%
DPS 9.30 4.30 2.30 4.00 11.00 10.00 8.50 6.16%
NAPS 0.344 0.299 0.273 1.36 1.29 1.32 1.37 -60.09%
Adjusted Per Share Value based on latest NOSH - 261,705
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 334.09 284.71 136.73 55.06 189.08 145.05 101.70 120.50%
EPS 11.94 6.01 2.56 1.61 1.91 2.35 2.25 203.31%
DPS 8.45 3.91 2.09 0.73 2.00 1.81 1.54 210.13%
NAPS 0.3125 0.2716 0.2479 0.247 0.234 0.2394 0.2483 16.51%
Price Multiplier on Financial Quarter End Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 -
Price 0.74 0.835 5.29 3.26 5.00 4.32 2.22 -
P/RPS 0.20 0.27 3.51 1.08 0.48 0.54 0.40 -36.92%
P/EPS 5.63 12.61 187.92 36.88 47.56 33.39 17.91 -53.67%
EY 17.77 7.93 0.53 2.71 2.10 2.99 5.58 115.99%
DY 12.57 5.15 0.43 1.23 2.20 2.31 3.83 120.36%
P/NAPS 2.15 2.79 19.38 2.40 3.88 3.27 1.62 20.70%
Price Multiplier on Announcement Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 -
Price 0.76 0.845 0.925 4.03 3.49 5.72 4.42 -
P/RPS 0.21 0.27 0.61 1.33 0.33 0.72 0.79 -58.55%
P/EPS 5.78 12.76 32.86 45.59 33.20 44.21 35.66 -70.17%
EY 17.30 7.84 3.04 2.19 3.01 2.26 2.80 235.59%
DY 12.24 5.09 2.49 0.99 3.15 1.75 1.92 242.65%
P/NAPS 2.21 2.83 3.39 2.96 2.71 4.33 3.23 -22.29%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment